Follow The Filings

VBIO Valion Bio

Valion Bio earnings company data as of 4:47 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 14 Aug EPS — -2.17 —
Rev — — —

Insider trades

Open-market buys and sales by VBIO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VBIO insider trades
  • $28K bought by 2 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Sheryle Bolton Director
    Buy
    $10K 10,000 shares at $1.04 New stake
    Traded Apr 15 Filed Apr 20
    ↗
  2. Christina Rizopoulos Valauri Director
    Buy
    $18K 19,000 shares at $0.9500 New stake
    Traded Apr 1 Filed Apr 2
    ↗

Also filed in the last 12 months, not counted as buying or selling: 7 option exercises and 3 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
424B3 Filing Doc
DEF 14A DEFINITIVE PROXY STATEMENT Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,3.02,5.02,7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 3.03,5.03,7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K/A 5.07 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 3.02,5.02,5.07,8.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q FORM 10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,3.02,8.01 Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated about 15 hours ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.